Screener
Vera Therapeutics VERA Q2 2026 earnings
Reported August 10, 2026 · After market close
EPS-$1.52Beat by $0.06
Revenue estimate$1.3M
EPS estimate-$1.58
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$4.3M
EPS estimate-$1.62
Versus estimates
Diluted EPS
FAQ
- When did Vera Therapeutics report Q2 2026 earnings?
- Vera Therapeutics (VERA) reported Q2 2026 earnings on August 10, 2026 after market close.
- What were Vera Therapeutics's Q2 2026 revenue and EPS?
- Vera Therapeutics reported eps of $-1.52 for Q2 2026.
- Did Vera Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-1.58 by $0.06.
- How did Vera Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 26.7% from $-1.20.
- Where can I find Vera Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-342335) and the 10-Q periodic report (0001193125-26-342380) directly on SEC EDGAR. The filing index links above go to sec.gov.
